Official UK procurement notice
NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets
Authority: NHS England (Central government)
What is being bought
Published requirement descriptionProject title: NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets
Offer reference number: CM/TNS/26/5745
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.
CM/TNS/26/5745 Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg
Lot 1 DNE, LNW & SOFE 1 November 2026 to 31 October 2027 (12 months)
Lot 2 DNW & MAE 1 November 2026 to 31 October 2027 (12 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
CPV: Pharmaceutical products
How this framework works
From the published notice- Type
- Open framework
- Call-offs
- every call-off is a further competition among the appointed suppliers
- Bids received
- 4 bids received · 4 suppliers appointed
- Framework period
- 1 yr · up to 3 yrs from 1 Nov 2026
Who may buy through it
Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points
Published description of the framework
Please refer to the ITO Documents for the Operation Description
The lotProcurement structure
single lot · value publishedLot #1AwardedRenewalPublished value£5,400,000
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (1)
- Price is not the only award criterion: 100%
Published award criteria (1)
- Price is not the only award criterion
- Price carries 100 of 100 points: a 10% discount moves about 10 points. This one is won on the number: sharpen the price before polishing the prose.
- “NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg…” is a framework: the contest is a place on its panel, not a single contract: each call-off is a further competition, so the pricing contest starts after appointment.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record- Procedure method
- Open procedure
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Above threshold (FTS publication)
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use the vehicle
- Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 12 Mar 2026, 15:56 GMT
- Last source update
- 2 Sept 2026, 14:59 BST
- Award evaluation window
- Submission end – 29 Jul 2026
- Authority reference
CM/TNS/26/5745- FTS notice number
2026/S 000-052395- Latest notice
- Contract details notice (UK7)
- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-0668c0Find a Tender
How it was run
Official notice- Appointment period ends
- 1 Jul 2026, 13:00 BST
- Clarification deadline
- 24 Jun 2026, 12:00 BST
- Submission channel
- Official e-sourcing portal
- Electronic submission
- Allowed
- Accepted languages
- en
The procurement documents are available for unrestricted and full direct access, free of charge at health-family.force.com/s/Welcome ↗
Additional info obtained from the abovementioned address
Tenders must be submitted to the abovementioned address
Timeline
12 Mar 2026 → 1 Nov 2026 · 10 dates- Planning notice published218 days ago12 Mar 2026, 15:56 GMT
- Market engagement169 days ago30 Apr 2026, 23:59 BST
NHS England is seeking to engage with current or potential new suppliers that are planning to launch any of the molecules that will be covered by this procurement. Interested suppliers will be invited to a virtual preliminary market engagement meeting.
The purpose of these sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, and KPI's.
Please contact [email protected] or [email protected] to register your interest in tendering for this framework.
Please indicate which products your company is planning to bring to market in your response.
- Next notice expected142 days ago27 May 2026, 23:59 BST
- Tender notice published136 days ago3 Jun 2026, 14:19 BST
- Clarification questions by115 days ago24 Jun 2026, 12:00 BST
- Admission / appointment period ends108 days ago · period end, not a bid countdown1 Jul 2026, 13:00 BST
- Assessment summaries sent80 days ago29 Jul 2026, 00:00 BST
- Award decision expected by79 days ago29 Jul 2026, 23:59 BST
- Latest notice published45 days ago2 Sept 2026, 14:59 BST
- Today17 Oct 2026
- Contract startsin 15 days1 Nov 2026
Notice history
10 events · 5 releases on Find a Tender · since 12 Mar 2026- Pipeline notice published12 Mar 2026, 15:56 GMTUK1
- Preliminary market engagement notice published2 Apr 2026, 11:05 BSTUK2
- Tender notice published3 Jun 2026, 14:19 BSTUK4
- Published value updated to £5,400,0003 Jun 2026, 14:19 BSTwas £1,800,000
- Status changed to active3 Jun 2026, 14:19 BST
- Deadline published: 1 Jul 2026, 13:00 BST3 Jun 2026, 14:19 BST
- Contract award notice published29 Jul 2026, 15:55 BSTUK6
- Status changed to complete29 Jul 2026, 15:55 BST
- Contract signature expected21 Aug 2026, 23:59 BSTscheduled
- Contract details notice published2 Sept 2026, 14:59 BSTUK7
Routine re-releases (5)
- 2026-04: 1 release · 2 Apr 2026
- 2026-03: 1 release · 12 Mar 2026
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Lupin Healthcare UK LtdSME, Merck Sharp & Dohme UK Ltd, Orifarm UKSME, UNICORN PHARMACEUTICALS LIMITEDSME1 Nov 2026 – 31 Oct 2027 · up to 31 Oct 2029Extensions: Option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. | £8,545,000 | 29 Jul 2026 | Awarded |
Contracts
NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets · Lupin Healthcare UK LtdSME, Merck Sharp & Dohme UK Ltd, Orifarm UKSME, UNICORN PHARMACEUTICALS LIMITEDSME
- Signed
- 12 Aug 2026
- Value
- £8,545,000
- Period
- 1 Nov 2026 – 31 Oct 2027 · up to 31 Oct 2029 with extensions
- Status
- active
- Extensions
- Option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 4final-stage tenders | 3 | 0 | — |
Who bid
- wonMerck Sharpe & Dohme (UK) Limited · Greater London
- wonOrifarm UKSME · East of England
- wonUnicorn Pharmaceuticals LtdSME · Greater London
- wonLupin Healthcare (UK) LimitedSME · South East England
Bidders as named on the Procurement Act 2023 award notice. “Won” means the bidder holds an award on this notice.
Contracting authority & participating public bodies
Framework contractors & participating bidders
4 commercial parties on the notice- Lupin Healthcare (UK) LimitedFramework contractor
- Merck Sharpe & Dohme (UK) LimitedFramework contractor
- Orifarm UKFramework contractor
- Unicorn Pharmaceuticals LtdFramework contractor
Official documents & specifications (18)
Official links; attachments are not copiedTender pack and attachments
- Bidding documents and specifications Document No. 05a Selectt offer schedule - CM_TNS_26_5745_01
- Bidding documents and specifications Document No. 05b Tender Product Listing and Usage - CM_TNS_26_5745_01
- Bidding documents and specifications Document No. 06 - Form of offer - CM-TNS-26-5745
- Bidding documents and specifications Document No. 07 - Quality control technical sheet - CM-TNS-26-5745
- Bidding documents and specifications Document No. 03 - Framework Agreement and Terms and Conditions - CM-TNS-26-5745
- Bidding documents and specifications Document No. 09 - Pharmacy Purchasing Points List - CM-TNS-26-5745
- Bidding documents and specifications Document No. 10 - C434009 - Requirement Section 1. Procurement Specific Questionnaire (PSQ) CM-TNS-26-5745
- Signed contract UK7 CONTRACT COPY CM-TNS-26-5745 Etravirine Raltegravir Ritonavir
Show 5 more documents
- Bidding documents and specifications Document No. 08 - Confidential information schedule - CM-TNS-26-5745
- Bidding documents and specifications Document No. 01 - Invitation to offer covering letter - CM-TNS-26-5745
- Bidding documents and specifications Document No. 02 - Terms of offer - CM-TNS-26-5745
- Bidding documents and specifications Document No. 04 - Quality Assurance Process - CM-TNS-26-5745
- Bidding documents and specifications Document No. 05 - Selectt offer schedule instructions - CM-TNS-26-5745
Notices published for this procedure
- Contract details notice Contract details notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Tender notice Tender notice on Find a Tender
- Preliminary market engagement notice Preliminary market engagement notice on Find a Tender
- Pipeline notice Pipeline notice on Find a Tender